Sign in
4

Changes in Ownership

Replimune Group, Inc. Filed Acc 0001104659-25-031832

Chief Medical Officer acquired 45,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Xynos Konstantinos Chief Medical Officer 2025-04-01 Grant or award +45,000 154,885 D
Derivatives
Xynos Konstantinos Chief Medical Officer 2025-04-01 Grant or award · Employee Stock Option (right to buy) +67,500 67,500 D
Loading xslF345X05/tm2511407-8_4seq1.xml…